Survey 11 - Role of Triple Drug Combination in Productive Cough ManagementMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max File Size 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size 2 MB)Choose File Questionnaire (Version 2) on Patient Profiles, Comorbidities & Efficacy of Levosalbutamol + Ambroxol + Guaifenesin Combination Formulation1. In which age group do you most frequently prescribe the combination of levosalbutamol + ambroxol + guaifenesin for cough, chest congestion, and other bronchial symptoms? Infants & toddlers (0-2 years) Young children (under 12 years) Teenagers (13-18 years) Adults (18-60 years) Seniors (60-75 years) Elderly (Above 75 years) All of the above2. What are the most common indications in paediatric patients for which you prescribe a combination of levosalbutamol + ambroxol hydrochloride + guaifenesin? Tenacious mucus secretions Persistent cough that disrupts sleep or leads to crying Wheezing or sound while breathing Cough associated with Respiratory tract infections3. What are the most common indications in adults/elderly patients for which you prescribe a combination of levosalbutamol + ambroxol hydrochloride + guaifenesin? Acute bronchitis Bronchial asthma Cough associated with Respiratory tract infections COPD4. In what percentage of your patients with persistent and severe cough do you prescribe the combination of Levosalbutamol + ambroxol hydrochloride + guaifenesin? Less than 25% 25-50% 50-75% More than 75%5. What are the benefits you perceive in prescribing a combination of levosalbutamol + ambroxol hydrochloride + guaifenesin for treatment of productive cough and associated bronchial symptoms? Comprehensive relief from symptoms of productive cough, wheezing, bronchospasms Clears airways to reduce wheezing Improve quality of life All of the above6. What percentage of your patients who present with severe or persistent cough also have concomitant COPD or asthma? Less than 25% 25-50% 50-75% More than 75%7. What duration of action do you observe for symptom relief after administration of syrup or drops containing these 3 active ingredients? Immediate (within 30 minutes) 1-2 hours 4-6 hours More than 6 hours Other (Please mention)Others (Please Mention)8. What percentage of your adult patients report relief from persistent coughing after using the combination of levosalbutamol + ambroxol + guaifenesin for 3-4 days? Less than 25% 25-50% 50-75% More than 75%9. Do you use this triple combination therapy (levosalbutamol + ambroxol + guaifenesin) alongside other treatments? If so, what types? Yes, antibiotics Yes, antihistamines Yes, corticosteroids No, used alone10. Do you think the combination of levosalbutamol + ambroxol + guaifenesin is well-tolerated by most of your patients? Yes, well-tolerated Moderately tolerated Occasional issues No, not well-tolerated11. How would you rate the efficacy of the combination of levosalbutamol + ambroxol + guaifenesin? Excellent Good Fair Poor12. How would you rate the safety of the combination of levosalbutamol + ambroxol + guaifenesin? Excellent Good Fair Poor13. How would you rate the adherence of the combination levosalbutamol + ambroxol + guaifenesin? Excellent Good Fair Poor14. What is the primary reason you prefer prescribing the combination of levosalbutamol + ambroxol + guaifenesin for persistent and/or productive cough? Good tolerance Fast relief from troublesome symptoms (patient-reported) Good adherence to therapy Excellent safety profile All of the above I have read and agree to the Terms and Conditions .Submit Form